08-Dec-2022 By Nick Taylor
Metrion Biosciences has leased a new facility and added high-throughput screening (HTS) capacity to support its ion channel drug discovery projects.
10-Sep-2020 By Jenni Spinner
The clinical research service provider is opening a new CRO site in the UK to meet growing demand from biotech industry clients.
01-Jun-2020 By Jenni Spinner
A leader from the contract research organization explains how determining endpoints for such trials may require a different approach than for adults.
13-Feb-2020 By Vassia Barba
Aiming to support drug developers in issues related to market insights, engagement, and access, Synaptiq enters the market backed by three consultancy agencies.
03-Oct-2019 By Vassia Barba
LGC announces the addition of Quanterix’s HD-X platform to its offering, enabling automated development and performing of immunoassays for ‘unprecedented insights’ into disease biology as well as drug efficacy and safety.
06-Sep-2018 By Melissa Fassbender
The outsourced service providers have signed a new collaboration agreement to provide global pharmaceutical and biotechnology clients access to electrophysiology and ion channel screening.
29-Sep-2016 By Dan Stanton
The US FDA has placed a Phase III trial for Cel-Sci’s head and neck cancer candidate on clinical hold.
18-Jul-2016 By Gareth Macdonald
Parexel has confirmed that CFO Ingo Bank has resigned a little over three years after joining the US contract research organisation (CFO).
13-Nov-2015 By Dan Stanton
Quintiles will provide its open source code to tech giant Apple’s ResearchKit framework to help create more efficient and integrated clinical trial apps.
22-Oct-2014 By Gareth Macdonald
Icon says it has signed more deals with biotech customers and is seeing more interest for adaptive trial designs.
CRO should stand for contract research organisation say readers
21-Nov-2012 By Gareth Macdonald
Outsourcing-pharma.com readers want the acronym CRO to stand for 'contract research organisation' according to the results of a snap poll we ran yesterday.
20-Nov-2012 By Gareth Macdonald
Outsourcing-pharma.com witnessed a fascinating debate on the definition of ‘CRO’ yesterday with terms like 'collaboration' and 'release' being suggested as potential alternatives.
Icon has expanded its early-phase medical imaging services business, citing greater use of the technology in clinical development.
WuXi calls theft of two client compounds an “isolated case”
WuXi PharmaTech has called the theft of two compounds by an employee an “isolated case” and said it is upping oversight.
31-Oct-2011 By Natalie Morrison
Icon will this year focus its R&D efforts on gaining new grounds in genomics, said Brian O’Dwyer.Icon
Chiltern opens Chicago office
Chiltern has opened a new office in Bannockburn, Chicago.
PPD says income and revs grew in Q2 but analysts unconvinced
27-Jul-2011 By Gareth Macdonald
PPD posted an improved set of financials for Q2 days after announcing a review of its long-term plan and capital structure following speculation it was looking for a buyer.
Preclinical CRO CIToxLAB opens for business
23-Jun-2011 By Gareth Macdonald
CIToxLAB was officially launched this week, giving the preclinical research sector a new player with operations on both sides of the Atlantic.
LAB Research's Canadian lender appoints receivers
22-Feb-2011 By Gareth Macdonald
Lab Research's main Canadian lender has obtained an order appointing receivers under section 243 of the bankruptcy and insolvency act after the firm's US private equity suitor lost interest in a takeover.
PPD positive about 2011, plans further investments
20-Jan-2011 By Gareth Macdonald
PPD has issued upbeat guidance for 2011 and says it is confident about the fundamentals of the contract research sector.
PRA sets up Prague Ph I unit
PRA International has opened a new Phase I unit in Prague in the Czech Republic, continuing its recent expansion programme.
Symbios renamed MMD after post-acquisition integration
Symbios Clinical has been renamed Medpace Medical Device (MMD) after completing its integration with Medpace.
Appointments at INC Research, Emerald BioStructures and ClinOps – People on the move
02-Nov-2010 By Nick Taylor
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, Emerald BioStructures and ClinOps.
PPD sees Op income and revs climb in Q3; signs new collaborations
27-Oct-2010 By Gareth Macdonald
PPD signs clinical imaging and formulation development collaborations, reorganises reporting units and cites “improved performance in emerging markets” and spending controls as key to third quarter gains.
Outsourcing-pharma looks at imaging in drug development
09-Sep-2010 By Alexandria Pesic
Outsourcing-pharma takes a look at all the latest developments in the rapidly expanding drug development imaging sector with news from Aspect and Medisco, VirtualScopics and ABX-CRO and ACR Image Metrix.
Quintiles lands CF drug commercialisation contract
02-Sep-2010 By Gareth Macdonald
Quintiles will help Australian drugmaker Pharmaxis launch its cystic fibrosis treatment Bronchitol in Europe under a contract announced yesterday.
CRO NexMed raises $2.7m to develop delivery tech
10-Feb-2010 By Staff reporter
CRO NexMed has received a $2.7m (€2.0m) cash boost, which improves its financial situation and provides funds to develop its NexACT technology for oral and transdermal delivery.
Novotech expands in Asia with new Malaysian base
29-Oct-2009 By Gareth Macdonald
Novotech says its new “management hub” in Kuala Lumpur, Malaysia will serve as a base for expansion in the booming Asia-Pacific contract research sector.
Encorium terminates sale plans on success of vaccines strategy
21-Oct-2009 By Gareth Macdonald
Encorium has abandoned plans to sell its Finnish unit, Encorium OY, citing its new strategic focus and recent contract wins as the basis for the decision.
Benefits of SMS for trial recruitment are self-evident, says Axiom
30-Sep-2009 By Gareth Macdonald
Axiom Accelerated Patient Recruitment hopes its new range of SMS, text messaging, services can help CROs and pharma sponsors reach more potential study participants.
Averion plans going private to cut outgoings
07-Sep-2009 By Nick Taylor
CRO Averion is planning to become a private company to reduce expenditure on auditor fees, which could realise savings of $805,000 (€561,000), and allow management to better focus on long-term goals.
Encorium plans liquidation if subsidiary sold
25-Aug-2009 By Nick Taylor
Encorium plans to liquidate if it can negotiate the sale of its Finland-based business, which could happen in the fourth quarter.
PPD’s Q2 project cancellations just shy of “unprecedented” Q1 levels
22-Jul-2009 By Gareth Macdonald
PPD's woes have continued in the second quarter with revenue from its development segment down nearly 11 per cent to $330.2m (€232.5m).
Ability to hit deadlines, not cost, top CRO quality, survey finds
29-Apr-2009 By Antoine Durivaux
19 out of 21 pharmaceutical companies surveyed by Cutting Edge Information ranked a contract research organisation’s ability to hit trial deadlines as either “extremely important” or very “important,” making it the top quality identified by respondents.
Kendle’s income and cancellations surge
06-Nov-2008 By Nick Taylor
Kendle International has posted impressive third quarter results, despite seeing a dramatic increase in the number of contract cancellations during the period.
Medelis expands reach into Europe
US-based contract research organisation Medelis has founded a European division, Medelis Europe, to bring its expertise in oncology clinical trials design and management to customers wanting to launch drugs in Europe.
ClinPhone declines Parexel's advances
18-Feb-2008 By Kirsty Barnes
Leading eClinical provider ClinPhone has declined a preliminary
offer by Parexel to purchase the firm for an undisclosed sum.
Synexus agrees to private sale
12-Nov-2007 By Kirsty Barnes
Management of publicly-traded Synexus have agreed to the £18.1m
(€25.7m) sale of the company to a private equity firm that has
promised to fund its global expansion ventures.
PharmaNet back in the red; lawsuit settled
06-Aug-2007 By Kirsty Barnes
PharmaNet has reported second quarter results that place it back in
the red after it had only just clawed its way back into the black
in the first quarter, following a string of quarterly losses.
PPD to expand services biz in Scotland
31-Jul-2007 By Emilie Reymond
Pharmaceutical Product Development (PPD) is planning to expand its
operations in Scotland and more than double its workforce over the
next three years.
PPD posts strong Q2 results, cuts year outlook
23-Jul-2007 By Emilie Reymond
PPD has posted positive financial results for the second quarter of
the year in net contrast to its lacklustre performance in Q1, but
cut its earning outlook for the full year.
Nicholas Piramal opens second research site
14-Jun-2007 By Kirsty Barnes
Nicholas Piramal India (NPIL) has opened its second clinical
research facility and is eyeing the growing area of
Asterand outlines action for profitability
12-Jun-2007 By Kirsty Barnes
Asterand has announced a restructure and changes to its operational
model in a bid to grasp hold of profitability.
Pacific Biometrics, Neuren, Hesperion and Qualia Clinical Service – Clinical contract news
17-May-2007 By Emilie Reymond
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community this past week, involving Pacific
Biometrics, Neuren, Hesperion and Qualia Clinical Service.
Xcelience to expand headquarters in Florida
11-Oct-2006 By Emilie Reymond
Formulation development company Xcelience has announced its plan to
expand its headquarters in Tampa, Florida to meet higher customers'
Biophage completes Immunotoxicity division restructuring
22-May-2006 By Wai Lang Chu
Biophage has completed the final phase of its CRO business
restructuring in preparation to meet the expected demand in
immunotoxicity testing, in which its requirement stems from
increasing legislation that calls for stricter standards.